Je-Yeong Park

BioActs Co. Ltd. operates as a research and development company that produces fluorescent reagents for research of optical imaging and diagnosis, and optical contrast agents for animals. Its products include biochemical labeling, cell analysis, in vivo imaging, antibody, nucleic acid labeling, nanoparticles and beads and imaging instruments. The firm offers fluorescent labeling, organic synthesis, oligonucleotide synthesis service and licenses and B2B services. The company was founded in 1976 and is headquartered in Incheon, South Korea.

BioActs Co. Ltd. operates as a research and development company that produces fluorescent reagents for research of optical imaging and diagnosis, and optical contrast agents for animals. Its products include biochemical labeling, cell analysis, in vivo imaging, antibody, nucleic acid labeling, nanoparticles and beads and imaging instruments. The firm offers fluorescent labeling, organic synthesis, oligonucleotide synthesis service and licenses and B2B services. The company was founded in 1976 and is headquartered in Incheon, South Korea.

BioActs Co. Ltd. operates as a research and development company that produces fluorescent reagents for research of optical imaging and diagnosis, and optical contrast agents for animals. Its products include biochemical labeling, cell analysis, in vivo imaging, antibody, nucleic acid labeling, nanoparticles and beads and imaging instruments. The firm offers fluorescent labeling, organic synthesis, oligonucleotide synthesis service and licenses and B2B services. The company was founded in 1976 and is headquartered in Incheon, South Korea.

BioActs Co. Ltd. operates as a research and development company that produces fluorescent reagents for research of optical imaging and diagnosis, and optical contrast agents for animals. Its products include biochemical labeling, cell analysis, in vivo imaging, antibody, nucleic acid labeling, nanoparticles and beads and imaging instruments. The firm offers fluorescent labeling, organic synthesis, oligonucleotide synthesis service and licenses and B2B services. The company was founded in 1976 and is headquartered in Incheon, South Korea.

BioActs Co. Ltd. operates as a research and development company that produces fluorescent reagents for research of optical imaging and diagnosis, and optical contrast agents for animals. Its products include biochemical labeling, cell analysis, in vivo imaging, antibody, nucleic acid labeling, nanoparticles and beads and imaging instruments. The firm offers fluorescent labeling, organic synthesis, oligonucleotide synthesis service and licenses and B2B services. The company was founded in 1976 and is headquartered in Incheon, South Korea.